Richard C. Harkaway  European Urology Supplements 

Slides:



Advertisements
Similar presentations
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
Advertisements

Medical Management for BPH: The Role of Combination Therapy
Pascal Rischmann  European Urology Supplements 
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management  Michael O’Leary  European Urology Supplements 
Management of Acute and Chronic Retention in Men
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Bladder Cancer: A Major Public Health Issue
Back to the Future: Introduction and Conclusions
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 52, Issue 3, Pages (September 2007)
Treatment of Symptomatic Benign Prostatic Hyperplasia: Current and Future Clinical Practice in Europe – What is Really Happening?  Bob Djavan  European.
Counselling the Prostate Cancer Patient
Laurent Boccon-Gibod  European Urology Supplements 
Volume 52, Issue 4, Pages (October 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
An Update of Current Practice in Hypospadias Surgery
Volume 50, Issue 5, Pages (November 2006)
Tim Schneider  European Urology Supplements 
Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy  Bertrand Tombal, Richard Berges  European Urology.
Transurethral Resection of the Prostate
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH):
The Importance of Testosterone Control in Prostate Cancer
Bone Health in Patients With Prostate Cancer: Monitoring and Diagnosis
Optimal Testosterone Control and Eligard®
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
Neal Shore  European Urology Supplements 
When to Treat the Prostate, the Bladder, or Both?
The Hallmarks of BPH Progression and Risk Factors
Sergio Bracarda  European Urology Supplements 
What are the Data on 5α-Reductase Inhibitor Treatment of Benign Prostatic Hyperplasia from Everyday Practice?  François Desgrandchamps  European Urology.
Christian Stief  European Urology Supplements 
New Trends in Managing the Prostate Cancer Patient
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Emmanuel Chartier-Kastler, Kate Davidson  European Urology Supplements 
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Who Forms Stones and Why?
Martin Michel, Jean de la Rosette  European Urology Supplements 
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
Richard Berges  European Urology Supplements 
Improving Flexibility and Quality of Life for Your Patients: A Must?
Profile of Silodosin European Urology Supplements
New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men
Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis
The Increasing Responsibility of the Urologist in Maintaining Bone Health in Prostate Cancer Patients  Kurt Miller  European Urology Supplements  Volume.
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
The Benefits of Dual Inhibition of 5α Reductase
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
C.G Roehrborn, T McNicholas  European Urology Supplements 
Treatment Options in Prostate Cancer Once Primary Therapy Fails
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Counselling of the Prostate Cancer Patient as a Whole Person
Joaquim Bellmunt  European Urology Supplements 
Classification of Mixed Incontinence
The Impact of Premature Ejaculation on Partners and Relationships
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Diagnosis and Management of Cryptorchidism
Integrating Patient Risk Profiles in the Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) in Clinical Practice 
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Epidemiology and Demographics of Prostatitis
New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer  Noel W. Clarke  European Urology Supplements 
Jan Roigas  European Urology Supplements 
Michael Marberger  European Urology Supplements 
Introduction European Urology Supplements
Vassilios Tzortzis, Stavros Gravas, Jean J.M.C.H. de la Rosette 
Presentation transcript:

What are the Views of Patients and Urologists on Benign Prostatic Hyperplasia and Its Management?  Richard C. Harkaway  European Urology Supplements  Volume 6, Issue 6, Pages 454-459 (March 2007) DOI: 10.1016/j.eursup.2007.01.015 Copyright © 2007 Terms and Conditions

Fig. 1 The proportion of men rating their current health as “fair” or “poor” in a US survey of prostate enlargement [1]. European Urology Supplements 2007 6, 454-459DOI: (10.1016/j.eursup.2007.01.015) Copyright © 2007 Terms and Conditions

Fig. 2 Proportion of patients and physicians agreeing that patients are more concerned about long-term effects of enlarged prostate rather than symptoms in a US national survey [13]. European Urology Supplements 2007 6, 454-459DOI: (10.1016/j.eursup.2007.01.015) Copyright © 2007 Terms and Conditions